Forte Biosciences Inc. (FBRX)
7.75
-1.35 (-14.84%)
At close: Mar 03, 2025, 3:59 PM
7.68
-0.90%
After-hours: Mar 03, 2025, 04:00 PM EST
Forte Biosciences Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| PE Ratio | -0.82 | -1.25 | -1.38 | -3.41 | -4.15 | -3.36 | -3.85 | -7.35 | -9.85 |
| PEG Ratio | -0.03 | 0.03 | 0.02 | -0.02 | 0.04 | 0.41 | -0.07 | -0.22 | n/a |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | 9.13 | 3.65K | 5.02K | 4.45K |
| PB Ratio | 0.73 | 0.45 | 0.72 | 4.54 | -3.54 | 2.83 | 2.11 | 35.19 | 5.81 |
| P/FCF Ratio | -0.9 | -2.12 | -1.79 | -14.54 | -5.75 | -4.52 | -4.71 | -8.19 | -10.67 |
| P/OCF Ratio | -0.9 | -2.12 | -1.79 | -14.54 | -6.09 | -4.78 | -4.81 | -8.34 | -10.79 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -1.91 | -759.34 | -602.84 | -412.59 |
| Debt / Equity Ratio | n/a | n/a | n/a | n/a | -1.84 | 0.45 | 0.15 | 3.00 | 0.45 |
| Quick Ratio | 10.45 | 13.06 | 24.19 | 26.52 | 3.93 | 5.91 | 5.23 | 2.26 | 10.14 |
| Current Ratio | 10.45 | 13.06 | 24.19 | 26.52 | 3.93 | 5.91 | 5.23 | 2.26 | 10.14 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.17 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | -264.47 | -19.48 | 17.25 | 225.04 |
| Return on Equity (ROE) | -0.89 | -0.36 | -0.52 | -1.33 | 0.85 | -0.84 | -0.55 | -4.79 | -0.59 |
| Return on Assets (ROA) | -0.81 | -0.33 | -0.5 | -1.28 | -0.53 | -0.47 | -0.42 | -0.95 | -0.37 |
| Return on Capital (ROIC) | -0.92 | -0.36 | -0.52 | 0.30 | -0.71 | -0.53 | -0.5 | -1.51 | -0.41 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 100.00% | 100.00% | 100.00% | 100.00% |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -271.43% | -94.95K% | -68.32K% | -45.21K% |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -262.01% | -94.95K% | -68.32K% | -45.21K% |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -254.23% | -91.78K% | -64.68K% | -45.01K% |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | -202.02% | -77.53K% | -61.36K% | -41.71K% |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -242.26% | -89.52K% | -63.61K% | -44.09K% |